UChicago Medicine First Site in Illinois Offering Pioneering CAR T-Cell Therapy for Cancer

The FDA approved a breakthrough cancer treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma, that uses genetically engineered immune cells to target cancer.

Tags: , , , , , , , , ,

Read more

ASCO 2017, Olopade

ASCO Annual Meeting Brings Cancer Researchers to Chicago

More than 30,000 cancer leaders, physicians, researchers, and trainees gathered in Chicago in early June for the Annual Meeting of the American Society of Clinical Oncology (ASCO), the leading international professional organization for the clinical oncology community. We are always proud to contribute to the latest scientific and clinical advances being presented at the conference, […]

Tags: , , , ,

Read more

1 2 3 6